R1 RCM — Investor Presentation (December 2019)
33 slides from R1 RCM's investor presentation, Dec 27, 2019
Slide 1: Investor Presentation December 27, 2019
Exhibit 99.1 Investor Presentation December 27, 2019
Slide 2: Forward-Looking Statements and Non-GAAP Financial Measures
Forward-Looking Statements and Non-GAAP Financial Measures This presentation includes information that may constitute “forward-looking statements,” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future, not pa
Slide 3: R1 Investment Highlights
R1 Investment Highlights Leading end-to-end revenue cycle platform with highly compelling financial model DIFFERENTIATED LARGE HIGH RECURRING STRONG VALUE UNDERPENETRATED REVENUE AND GROWTH PROPOSITION MARKET Adj. EBITDA TRAJECTORY Operating $235-260M $100B 14% Model 2020 Adj. EBITDA Acute and Avera
Slide 4: We Drive Financial Improvement and a Better Patient Experience for Integrated Health Systems
We Drive Financial Improvement and a Better Patient Experience for Integrated Health Systems NEED VALUE ADD RESULT Growing We plug into health Lower costs, pressure to run providers’ existing IT faster collections revenue cycle systems and higher more efficiently revenue OPERATING MODEL + ▪Proprieta
Slide 5: Comprehensive Revenue Cycle Capabilities for Healthcare Providers
Comprehensive Revenue Cycle Capabilities for Healthcare Providers Care Setting Emergency Physician Acute Post-Acute Revenue Cycle Phases Order to Intake Care to Claim Claim to Payment Payment Models Fee-for-service Value-based Patient Self-pay We Transform Revenue Cycle Performance Across Care Setti
Slide 6: Demonstrated Revenue Momentum
Demonstrated Revenue Momentum Quarterly Revenue – $Millions $295 $301 $276 $263 $250 $208 $140 $147 $123 $87 $99 Q1'17 Q2'17 Q3'17 Q4'17 Q1'18 Q2'18 Q3'18 Q4'18 Q1'19 Q2'19 Q3'19 6
Slide 7: Financial Outlook
Financial Outlook $m 2019 2020 Revenue 1,175 – 1,200 1,250 – 1,400 GAAP Operating Income 55 – 70 140 – 170 Adjusted EBITDA 165 – 170 235 – 260 $m Contracted Growth1 Revenue 1,250 – 1,300 1,300 – 1,400 Adjusted EBITDA 245 – 260 235 – 245 Expected 2019 EBITDA Improvement of ~$100M Positions us well fo
Slide 8: Investment Highlights
Investment Highlights 1 Large, Underpenetrated Market R1 2 Differentiated Value Proposition Investment Thesis 3 Multiple Growth & Profit Drivers 8
Slide 9: Market Dynamics Play to Our Strengths
Market Dynamics Play to Our Strengths Hospital Market Implication for Need for Dynamics Hospitals Sustainable Solutions ▪ Financial ▪ Sub-optimal pressures collections rate Best value proposition ▪ Increasing ▪ Weakening complexity margins ▪ Infrastructure = ▪ Industry not delivering consolidation s
Slide 10: Large, Growing and Underpenetrated Market
Large, Growing and Underpenetrated Market $100B Market External RCM Spend …R1 Revenue Expected for RCM Services1 Growing Steadily2… to Grow Faster External 25% Spend Projected CAGR from ~$30B 2018 to 2020 Internal 12% Projected CAGR Spend through 2020 ~$70B $60B Acute-Care $40B Physician Target Mark
Slide 11: Investment Highlights
Investment Highlights 1 Large, Underpenetrated Market R1 2 Differentiated Value Proposition Investment Thesis 3 Multiple Growth & Profit Drivers 11
Slide 12: Comprehensive Approach to Transform Revenue Cycle
Comprehensive Approach to Transform Revenue Cycle WORKFLOW R1 PERFORMANCE STACKSM PATIENT ACCESS UTILIZATION, CHARGE & CODE CLAIMS & REIMBURSEMENT 1 2 3 4 5 6 7 8 9 10 11 12 13 Phys. Pre-Reg. / Financial Check-in Level of Case Charge Coding & Billing & Denials Customer Patient Pay Under- Order & Fin
Slide 13: Broad Portfolio of Technology Tools
Broad Portfolio of Technology Tools PATIENT ACCESS & EXPERIENCE YIELD & DENIAL MITIGATION ANALYTICS AUTOMATION Clinical and Scoring and Predictive Technical Personalization Analytics Appeals Actionable Order Integrated Yield-Based Web Service Performance Management Bill Pay Follow-Up Integration Mon
Slide 14: Ability to Scale is a Key Differentiator
Ability to Scale is a Key Differentiator Scaling Successfully is a Function of Several Key Variables Proven Reliable, Effective Strong Operating Scalable Capacity Talent Systems Infrastructure Planning ▪ Defined operating ▪ Ownership and ▪ Ability to support ▪ Planning & data- model and deployed tal
Slide 15: Scalable Infrastructure, Broadest RCM Capabilities
Scalable Infrastructure, Broadest RCM Capabilities High Major end-to-end Scalability Competitors Niche Competitors Low Single-focus Revenue Cycle Capabilities End-to-End 15
Slide 16: Strong Market Recognition
Strong Market Recognition Serves Customers 2015 2016 2017 Dec 31, 2018 RCM Vendor > 1,500 Beds 90 84.3 81.6 80 74.8 70 63.2 Score (out of 100) of (out Score 61.3 60 58.9 50 PX Platform BEST INNOVATIVE 2015 2016 2017 Dec 31, 2018 Average for KLAS Revenue NEW PRODUCT Cycle Outsourcing is 72.6 2018 HFM
Slide 17: Investment Highlights
Investment Highlights 1 Large, Underpenetrated Market R1 2 Differentiated Value Proposition Investment Thesis 3 Multiple Growth & Profit Drivers 17
Slide 18: Multi-faceted Approach to Growth
Multi-faceted Approach to Growth Provides visibility to EBITDA Contracted Business Rollout growth beyond 2020 Convert end-to-end pipeline New Business Wins Ramp-up modular channel Cross-sell into PAS base Selectively pursue acquisitions Expansion of Capabilities and fund internal initiatives Margin
Slide 19: Our 2019 Focus
Our 2019 Focus Drive Margin Expansion on Contracted Business Execute Digital Transformation Launch Physician Group Solution for IDNs Convert Pipeline to Growth 19
Slide 20: Contracted Business Drives Margin Expansion
Contracted Business Drives Margin Expansion Quorum Health, Physician Group1, and new Health System2 ($4.1B NPR) AMITA and Ascension Medical Group ($6B NPR) Intermountain ($5B NPR) Ascension Phase-2 and Wisconsin ($5B NPR) Ascension Phase-1 ($3B NPR) 2016 2017 2018 2019 2020 Year 1: Onboarding phase
Slide 21: Digital Transformation
Digital Transformation 1 Significant 2 Proven Technology is 3 Holistic Transformation Opportunity Ready to Scale Approach ▪ Highly manual costs ▪ Digital self-service ▪ Established strategic relationships with – Labor ~80% of cost – Patient experience (PX) in world-class partners: deployment – 18K F
Slide 22: Automation Example: Medicaid Eligibility
Automation Example: Medicaid Eligibility Historical: All Manual Processing Manual Steps to Secure Approval for Medicaid Benefits: 1.1 Account posted on worklist based on R1 rules 2.2 Visit Medicaid website and searches for patient 3.3 Read eligibility & application status 4.4 Document status 5.5 Tak
Slide 23: Extrapolating Across our Footprint
Extrapolating Across our Footprint Completed blueprinting first 4 of 13 core revenue cycle 3 Primary Levers functions for automation future state which represent… ▪ 30 – 40M manual touches per year 1 ▪ 3,000 – 3,500 FTEs required to manage the volume Robotic Process Automation Similar Automations to
Slide 24: 2019 Key Financial Priorities
2019 Key Financial Priorities 1 Margin Expansion from Onboarded Customers 2 Ensure Digital Transformation Drives Financial ROI 3 Capital Structure Improvement 24
Slide 25: Margin Expansion from Contracted Business
Margin Expansion from Contracted Business Expected Adjusted EBITDA1 % ~19% Revenue lift from Technology- performance driven improvement productivity Rationalize enhancement ~6% vendor spend Move work to shared services centers 2018 2020 Note1: Based on midpoints of current guidance ranges. 25
Slide 26: Digital Transformation Drives Financial ROI
Digital Transformation Drives Financial ROI Cost per Bot RPA provides additional benefits including Development Increased accuracy & service quality (one time) $20 – 40K by avoiding human errors Infrastructure Improved internal controls through / Licensing $10K detailed activity logging / auditing I
Slide 27: Capital Structure Improvement
Capital Structure Improvement Data as of 9/30/19 Cash $56 million in cash and cash equivalents $321 million Term Loan A at L+2.75% Debt $50 million Revolver at L+2.75% Common Stock 113 million shares outstanding • Equivalent to 104.5 million common shares as of 9/30/19 Convertible • 200,000 shares i
Slide 28: Financial Outlook
Financial Outlook $m 2019 2020 Revenue 1,175 – 1,200 1,250 – 1,400 GAAP Operating Income 55 – 70 140 – 170 Adjusted EBITDA 165 – 170 235 – 260 $m Contracted Growth1 Revenue 1,250 – 1,300 1,300 – 1,400 Adjusted EBITDA 245 – 260 235 – 245 Expected 2019 EBITDA Improvement of ~$100M Positions us well fo
Slide 29: Our 2019 Focus
Our 2019 Focus Drive Margin Expansion on Contracted Business Execute Digital Transformation Launch Physician Group Solution for IDNs Convert Pipeline to Growth 29
Slide 30: Appendix
Appendix 30
Slide 31: Contract Economics by Engagement Model
Contract Economics by Engagement Model Illustrative Revenue and EBITDA contribution based on typical $3B NPR Operating Partner Co-Managed Modular $M $M $M 120-150 70-80 30-50 30-40 15-20 10-20 5-15 10-20 3-12 3-12 ~(12) ~(2.0) Year 1 Year 5 Year 1 Year 5 Year 1 Year 5 Revenue contribution EBITDA con
Slide 32: Financial Model for Operating Partner Model
Financial Model for Operating Partner Model Illustrative Contribution from $3B NPR Customer Launch Growth Steady State 0 – 12 Months 12 – 36 Months 36+ Months ▪ Deploy transition resources ▪ Finalize employee transitions ▪ Continuous optimization: ▪ Perform financial assessment ▪ Transfers to Shared
Slide 33: Use of Non-GAAP Financial Measures
Use of Non-GAAP Financial Measures ▪ In order to provide a more comprehensive understanding of the information used by R1’s management team in financial and operational decision making, the Company supplements its GAAP consolidated financial statements with certain non-GAAP financial performance mea